| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |